Highly Expressive Bienzyme and Photothermal Effect Co-Enabled by the Co–O–Mn Bridge for Potentiating 1550 nm Light-Triggered Photodynamic Therapy
Development of single-atom nanocatalysts with photoresponsive and enzyme-like properties has opened innovative avenues for improving the tumor photodynamic therapy (PDT) effect. However, their further application was restricted by the insufficient adsorption/desorption for multireaction intermediates and poor light tissue penetration. Herein, we constructed mesoporous silica-supported, O-bridged asymmetric cobalt-manganese (Co-O-Mn) dual-atom nanozyme, coated on the surface of 1550 nm-excited upconversion (UC) nanoparticles and modified with polyethylene glycol (denoted as P/U@CoMn<sub>DA</sub>), for the PDT, thermal-enhanced enzyme dynamic therapy, and magnetic resonance imaging. Interestingly, the incorporation of Co-O-Mn sites not only selectively enhanced the catalase (CAT)- and oxidase (OXD)-like activities of the P/U@CoMn<sub>DA</sub>, but also suppressed the peroxidase-like reaction and endowed the nanocatalysts with a narrowed bandgap (1.25 eV). Experimental and theoretical analyses revealed that the incorporation of Co-O-Mn sites upshifted the d-band center and optimized the adsorption-dissociation equilibrium for the O-containing intermediates. Under the dual stimulation of 1550 nm irradiation and intratumoral acidity, the H<sub>2</sub>O<sub>2</sub> substrate was decomposed by CAT-like activity into O<sub>2</sub>, which was reduced to ·O<sub>2</sub><sup>-</sup> by UC-induced electrons and OXD-like activity, and further oxidized by holes to cytotoxic <sup>1</sup>O<sub>2</sub>. Leveraging its high photothermal conversion property (η = 52.8%) and bienzymatic cascade performances, P/U@CoMn<sub>DA</sub> exhibited desirable tumor growth inhibition (92.8%). This work established practicable paradigms for designing the biomedical nanozymes at the atomic level.
Authors
- Chang Li (ORCID: https://orcid.org/0000-0002-3267-1859)
- Y. S. Lin (ORCID: https://orcid.org/0000-0001-5905-8336)
- Jiawei Qu
- Shuang Liu (ORCID: https://orcid.org/0009-0009-4705-3875)
- Peiyao Wang (ORCID: https://orcid.org/0000-0003-0406-4952)
- Zhimin Tang (ORCID: https://orcid.org/0000-0002-9265-5578)
- Yong Lu
- Piaoping Yang
- Jiating Xu
- Qiang Wang
Institutions
- Harbin Engineering University (CN)
- Chinese Academy of Sciences (CN)
- Changchun Institute of Applied Chemistry (CN)
- Heilongjiang Academy of Forestry (CN)
- Material Sciences (United States) (US)
- State Key Laboratory of Rare Earth Resources Utilization
- Northeast Forestry University (CN)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1021/jacs.5c22189
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 21.28